Your browser doesn't support javascript.
loading
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.
Pomicter, Anthony D; Eiring, Anna M; Senina, Anna V; Zabriskie, Matthew S; Marvin, James E; Prchal, Josef T; O'Hare, Thomas; Deininger, Michael W.
Afiliación
  • Pomicter AD; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Eiring AM; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Senina AV; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Zabriskie MS; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Marvin JE; Flow Cytometry Shared Resource, University of Utah, Salt Lake City, UT, USA.
  • Prchal JT; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
  • O'Hare T; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
  • Deininger MW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA. Electronic address: michael.deininger@hci.utah.edu.
Exp Hematol ; 43(7): 537-45.e1-11, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25912019
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Janus Quinasa 2 / Terapia Molecular Dirigida / Compuestos Heterocíclicos con 3 Anillos / Trastornos Mieloproliferativos / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Exp Hematol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Janus Quinasa 2 / Terapia Molecular Dirigida / Compuestos Heterocíclicos con 3 Anillos / Trastornos Mieloproliferativos / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Exp Hematol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos